Hola,
Are you new here?

XTremedy Medical

financed

Developing a surgical infection treatment to reduce amputations, healing times a...

Developing a surgical infection treatment to reduce amputations, healing times and hospital stays for diabetic foot patients XTremedy Medical is a surgical ablation company founded in 2018 to commercialize technology treating deep wound infections, including Diabetic Foot Infections (DFI). Our pulsed field ablation (PFA) system is the first to deliver e... see more

31/12/2022

XTREMEDY MEDICAL

75K€

Project Budget: 75K€

Project leader

XTREMEDY MEDICAL LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

PARTICIPATION DEPralty Sin fecha límite de participación.

Financing granted El organismo HORIZON EUROPE notifico la concesión del proyecto The day 2022-12-31

HORIZON-EIE-2021-SCALEUP-01-03: Women TechEU Expected Outcome:

Innovación

Cerrada

0% 100% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

XTREMEDY MEDICAL

75.00K€ | Leader

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project duration: 6 months Date Start: 2022-06-20
End date: 2022-12-31

Project leader

XTREMEDY MEDICAL LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

Project Budget 75K€

participation deadline Sin fecha límite de participación.

Project description XTremedy Medical is a surgical ablation company founded in 2018 to commercialize technology treating deep wound infections, including Diabetic Foot Infections (DFI). Our pulsed field ablation (PFA) system is the first to deliver electrical currents non-invasively to achieve superior clinical outcomes including faster cure of infections, reduced surgeries and shorter hospital stays. The Problem: Deep tissue and bone infections are life threatening infections that affect a millions of Europeans every year. Immunosuppressed patients are particularly vulnerable, with Diabetic Foot Ulcer Infections a leading cause of amputations in Europe. These patients are incredibly difficult to treat, requiring multiple surgeries, lengthy hospital stays and long-term antibiotics. In 20% of patients, an amputation is required to control the infection. Surgical intervention to remove infected tissue is the cornerstone of treatment but surgeons must balance removing infected material whilst preserving healthy tissue required for healing. Treatment Landscape: Current treatment modalities either only treat the surface of the wound or use mechanical forces to treat below the surface. Surface treatments fail as they leave infection below the wound bed untreated. Mechanical devices can cause more severe infections by damaging the integrity of the wound bed and propelling the infection deeper. As a result, these treatments are often ineffective, with 50% of patients requiring additional surgeries. XTremedy Solution: XTremedy Medical have developed a surgical device that delivers electrical signals through the wound. This device treats both the surface and below to zap any residual infection. The technology is non-thermal and preserves the integrity of the wound during treatment, helping reduce the time required for healing. Patients benefit from reduced surgeries, shortened hospital stays and antibiotic durations following surgery.

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers